These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16020942)

  • 1. Dimensions of executive function in Parkinson's disease.
    Weintraub D; Moberg PJ; Culbertson WC; Duda JE; Katz IR; Stern MB
    Dement Geriatr Cogn Disord; 2005; 20(2-3):140-4. PubMed ID: 16020942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporary deterioration of executive function after subthalamic deep brain stimulation in Parkinson's disease.
    Yamanaka T; Ishii F; Umemura A; Miyata M; Horiba M; Oka Y; Yamada K; Okita K; Matsukawa N; Ojika K
    Clin Neurol Neurosurg; 2012 May; 114(4):347-51. PubMed ID: 22176916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of executive impairment in mild to moderate Parkinson's disease.
    Kudlicka A; Clare L; Hindle JV
    Dement Geriatr Cogn Disord; 2013; 36(1-2):50-66. PubMed ID: 23774679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom Dimensions of Depression and Apathy and Their Relationship With Cognition in Parkinson's Disease.
    Szymkowicz SM; Dotson VM; Jones JD; Okun MS; Bowers D
    J Int Neuropsychol Soc; 2018 Mar; 24(3):269-282. PubMed ID: 29032789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apathy in Parkinson's disease. Impairment in quality of life].
    Bottini Bonfanti A; Etcheverry JL; Persi GG; Zezza H; Starkstein S; Gatto EM
    Medicina (B Aires); 2009; 69(2):253-8. PubMed ID: 19435698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The independent influence of apathy and depression on cognitive functioning in Parkinson's disease.
    Butterfield LC; Cimino CR; Oelke LE; Hauser RA; Sanchez-Ramos J
    Neuropsychology; 2010 Nov; 24(6):721-30. PubMed ID: 20853956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Unique and Combined Effects of Apathy and Depression on Cognition in Parkinson's Disease.
    Cohen ML; Aita S; Mari Z; Brandt J
    J Parkinsons Dis; 2015; 5(2):351-9. PubMed ID: 25769262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive performance in nondemented nonpsychotic Parkinson disease patients with or without a history of depression prior to the onset of motor symptoms.
    Klepac N; Hajnsek S; Trkulja V
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):15-26. PubMed ID: 19996416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.
    Pedersen KF; Larsen JP; Alves G; Aarsland D
    Parkinsonism Relat Disord; 2009 May; 15(4):295-9. PubMed ID: 18801696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease.
    Michely J; Barbe MT; Hoffstaedter F; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
    Neuropsychologia; 2012 Aug; 50(10):2506-14. PubMed ID: 22776611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychomotor and executive functioning after unilateral posteroventral pallidotomy in patients with Parkinson's disease.
    Olzak M; Laskowska I; Jelonek J; Michalak M; Szolna A; Gryz J; Harat M; Gorzelanczyk EJ
    J Neurol Sci; 2006 Oct; 248(1-2):97-103. PubMed ID: 16824546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive dysfunction in Parkinson's disease: a review.
    Dirnberger G; Jahanshahi M
    J Neuropsychol; 2013 Sep; 7(2):193-224. PubMed ID: 24007368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of specific executive functions on driving performance in people with Parkinson's disease.
    Ranchet M; Paire-Ficout L; Uc EY; Bonnard A; Sornette D; Broussolle E
    Mov Disord; 2013 Dec; 28(14):1941-8. PubMed ID: 24114952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the executive function deficits of patients with Parkinson's disease: utility of the Tower of London-Drexel.
    Culbertson WC; Moberg PJ; Duda JE; Stern MB; Weintraub D
    Assessment; 2004 Mar; 11(1):27-39. PubMed ID: 14994951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apathy may herald cognitive decline and dementia in Parkinson's disease.
    Dujardin K; Sockeel P; Delliaux M; Destée A; Defebvre L
    Mov Disord; 2009 Dec; 24(16):2391-7. PubMed ID: 19908317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and affective functioning in Parkinson's disease patients with lateralized motor signs.
    St Clair J; Borod JC; Sliwinski M; Cote LJ; Stern Y
    J Clin Exp Neuropsychol; 1998 Jun; 20(3):320-7. PubMed ID: 9845159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of performance-based measures of instrumental activities of daily living in nondemented patients with Parkinson's disease.
    Pirogovsky E; Martinez-Hannon M; Schiehser DM; Lessig SL; Song DD; Litvan I; Filoteo JV
    J Clin Exp Neuropsychol; 2013; 35(9):926-33. PubMed ID: 24074137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional capacity of Brazilian patients with Parkinson's disease (PD): relationship between clinical characteristics and disease severity.
    Barbieri FA; Rinaldi NM; Santos PC; Lirani-Silva E; Vitório R; Teixeira-Arroyo C; Stella F; Gobbi LT;
    Arch Gerontol Geriatr; 2012; 54(2):e83-8. PubMed ID: 21963176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.